Helicobacter pylori and atherosclerosis: Can current data be useful for clinical practice?

References 

1. Pellicano R, Fagoonee S. Helicobacter pylori and atherosclerosis : can current data be useful for clinical practice?. Int J Cardiol. 2009;135:e76–e77
   • Full Text
   • Full-Text PDF (95 KB)
   • CrossRef
2. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229–238
   • Abstract
   • Full Text
   • Full-Text PDF (574 KB)
   • CrossRef
3. Cammarota G, Pasceri V, Gasbarrini A, Gasbarrini G. Helicobacter pylori as an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis. 2000;32(1):65–68
   • Abstract
   • Full-Text PDF (1937 KB)
   • CrossRef
4. World Health Organization . Non Communicable Diseases: A Strategy for the African Region. Harare: WHO Regional Office for Africa; 2000;
5. Longo-Mbenza B, Lukoki Luila E, Phanzu Mbete, Kintoki Vita E. Is hyperuricémie a risk factor of stroke and coronary heart disease among Africans?. Int J Cardiol. 1999;71:17–22
   • Abstract
   • Full Text
   • Full-Text PDF (270 KB)
   • CrossRef
6. Hill AB. The environment and disease: association or causation?. Proc R Soc Med. 1965;58:295–300
   • MEDLINE
7. Elizalde JI, Perez-Pujol S, Heras M, et al. Effect of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter. 2004;9:681–689
   • MEDLINE
   • CrossRef
8. Nkondi Nsenga J, Ngo-Mbenza B, Abongo Mpolesha JM, Mabwa L, Mbungu S, Vangu D. Seropositivity for Helicobacter pylori and Helicobacter pylori gastritis and correlation with blood pressure parameters: evidence of cardiovascular risk. J Afr Hepato Gastroenterol. 2007;1:87–92[http://www.springerlink.com/content/6x5555825r58v742/]